BLRX

BioLineRX

25 hedge funds and large institutions have $33.1M invested in BioLineRX in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$98K
2 +$29.3K
3 +$9.09K
4
OC
Oppenheimer & Co
New York
+$9K
5
Ameriprise
Ameriprise
Minnesota
+$9K

Top Sellers

1 -$684K
2 -$195K
3 -$106K
4
Morgan Stanley
Morgan Stanley
New York
-$104K
5
Deutsche Bank
Deutsche Bank
Germany
-$78K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$23.5M
2
$6.9M
3
$924K
4
$900K
5
$222K
6
$127K
7
$98K
8
$67K
9
$62K
10
$52K
11
$44K
12
$32K
13
$31K
14
$27K
15
$15K
16
$9K
17
$9K
18
$7K
19
$6K
20
$5K
21
$3K
22
$3K
23
$2K
24
$1K
25
$178